Virtus ETF Advisers LLC Albireo Pharma, Inc. Transaction History

Virtus ETF Advisers LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$21.19 - $31.29 $131,314 - $193,904	-6,197 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$27.36 - $35.98 $8,919 - $11,729	-326 Reduced 5.0%	6,197 $193,000
Q2 2021 Aug 10, 2021	SELL	$28.9 - $36.87 $23,206 - $29,606	-803 Reduced 10.96%	6,523 $229,000
Q1 2021 May 17, 2021	BUY	$32.03 - $42.85 $4,292 - $5,741	134 Added 1.86%	7,326 $258,000
Q4 2020 Feb 12, 2021	BUY	$31.56 - $42.16 $226,979 - $303,214	7,192 New	7,192 $270,000
Q4 2018 Feb 05, 2019	SELL	$20.9 - $32.57 $297,616 - $463,796	-14,240 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$29.29 - $36.87 $306,021 - $385,217	-10,448 Reduced 42.32%	14,240 $469,000
Q2 2018 Aug 10, 2018	BUY	$28.9 - $37.31 $713,483 - $921,109	24,688 New	24,688 $876,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.